Galera Therapeutics rises as Q4 net loss narrows

Obsidian Therapeutics

10/03/2022 16:26

** Drug developer Galera Therapeutics' shares  GRTX.O  rise
3.6% to $2.32  
    ** GRTX's Q4 net loss narrows to $16.8 mln from $20.1 mln a
year ago, helped by lower research and development expenses
 urn:newsml:reuters.com:*:nGNX5RlWyt
    ** Stock down 49.5% YTD, including session's gains

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))